The effect of modeling and role modeling theory on nurturing body image and satisfying needs of colorectal cancer patients
Ontology highlight
ABSTRACT:
DISEASE(S): Colorectal Cancer,Malignant Neoplasm Of Colon
PROVIDER: 2493809 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
Similar Datasets
Project description:Intervention 1: Intervention group1: Interventions included holding educational sessions, distribution of educational aids tools such as pamphlet, film and free access to fecal occult blood test. Intervention 2: Intervention group2: Interventions included holding educational sessions, distribution of educational aids tools such as pamphlet and film. Intervention 3: Intervention group3: free access to fecal occult blood test. Intervention 4: Control group: For the control group will not perform any of the action that will be taken for the intervention group.;Prevention;Prevention;Prevention;Prevention;Intervention group1: Interventions included holding educational sessions, distribution of educational aids tools such as pamphlet, film and free access to fecal occult blood test;Intervention group2: Interventions included holding educational sessions, distribution of educational aids tools such as pamphlet and film;Intervention group3: free access to fecal occult blood test;Control group: For the control group will not perform any of the action that will be taken for the intervention group.
Primary outcome(s): Perceived severity. Timepoint: Before and 4 months after intervention. Method of measurement: Questionnaire.;Knowledge. Timepoint: Before and 4 months after intervention. Method of measurement: Questionnaire.;Perceived susceptibility. Timepoint: Before and 4 months after intervention. Method of measurement: Questionnaire.;Intention. Timepoint: Before and 4 months after intervention. Method of measurement: Questionnaire.;Perceived barriers. Timepoint: Before and 4 months after intervention. Method of measurement: Questionnaire.;Social support. Timepoint: Before and 4 months after intervention. Method of measurement: Questionnaire.;Self efficacy. Timepoint: Before and 4 months after intervention. Method of measurement: Questionnaire.;Perceived benefits. Timepoint: Before and 4 months after intervention. Method of measurement: Questionnaire.
Study Design: Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Screening.
| 2485950 | ecrin-mdr-crc
Project description:Intervention 1: Intervention group: At the time of admission of patients in the hospital, at the first session, filling out a questionnaire on quality of life in these patients and measuring the BMI will be carried out. Then, the patients will be evaluated by the form of the most common complications of patients under American Cancer Chemo Chemotherapy and then prioritizing the complications. Based on life threatening and post-traumatic training on complications according to the complications noted to the patient and his family on the second day of education in the field of complications according to the complications noted to the patient and his family on the third day of education in the field of complications according to the complications noted to the patient and his family The training time will be 45-60 minutes per session. The third, fifth and fifth days after discharge, according to the priority of the specified complications, will be sent to the patients ‘mobile phone. One month after the first assessment at the time of referral to the hospital, patients’ quality of life was assessed using a questionnaire and body mass index using weight and size Will be done. Intervention 2: Control group: In the control group, on the first day of admission, filling in the quality of life measurement and body mass index in the hospital, then measuring the quality of life and BMI will be done one month after the first assessment.
Primary outcome(s): Quality of life. Timepoint: At the beginning of the study, the month after the study. Method of measurement: The EROTIC core quality of life questionnaire.;Body Mass index. Timepoint: At the beginning of the study, the month after the study. Method of measurement: Digital weight and meter measurement scale.
Study Design: Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance.
| 2494782 | ecrin-mdr-crc
Project description:Gene expression data from Vietnamese subjects admitted to hospital with acute uncomplicated (n=6) or complicated (n=6) Plasmodium falciparum malaria infection had whole-blood samples collected at admission, 1 week later and 1 month later. Groups of assays that are related as part of a time series. Disease State: patient with complicated or uncomplicated Plasmodium falciparum malaria infection or Healthy control
2016-02-15 | GSE35859 | GEO
Project description:Gene expression data from whole-blood collected from Kenyan children with Plasmodium falciparum malaria infection at acute hospital admission (n=15) and at convalescence (n=9). A clinical history design type is where the organisms clinical history of diagnosis, treatments, e.g. vaccinations, surgery etc. Disease State: with Plasmodium falciparum malaria infection at acute hospital admission and at convalescence
2016-02-15 | GSE35860 | GEO
Project description:Intervention 1: Intervention group: Family members of the colon cancer patients who will be trained in attendance at the training sessions organized by the presenter. The two-week training session will be held for 1.5 hours with a two-week interval, the contents of the protocols’ training sessions are based on the results of the research and are based on authoritative references and books on colon cancer and approved by the Oncology Department of the University where the project was implemented. Also, answering the questions of patients in specialized medical fields will be done with an oncologist’s consultation and the result will be announced to them. Intervention 2: Control group: Family members of patients with colon cancer who undergo routine training provided by health center staff.
Primary outcome(s): Supportive care needs. Timepoint: At the beginning of the study, one month after the intervention. Method of measurement: A Survey of Supporting Care Needs Assessment Questionnaire(SCNS P&C39).;Health system & information needs. Timepoint: At the beginning of the study, one month after the intervention. Method of measurement: Health system & information dimension of SCNS-P&C39.;Psychological needs. Timepoint: At the beginning of the study, one month after the intervention. Method of measurement: Psychological dimension of SCNS-P&C39.;Job and social needs. Timepoint: At the beginning of the study, one month after the intervention. Method of measurement: Job and social dimension of SCNS-P&C39.
Study Design: Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Caregivers who have the conditions for participation in the study are included in the target (accessible or simple) sampling and will be randomly assigned as blocks in the intervention (A) and control (B) group. First, 15 blocks of four are defined as follows:ABAB, BBAA, BABA, BAAB, AAAB, ABBA, etc., and then these blocks are arranged randomly and individuals in A and B will be placed in two groups of intervention and control; this will continue until the sample size is completed. Family member A will be placed in the control group and B will be in the control group so that the sequence of samples will be random.After explaining the goals of the study and how the plan will be done for the patient and the family caring for them, oral consent will be given to them for participation in the study. Researchers will be assured that their infor
| 2495297 | ecrin-mdr-crc
Project description:Intervention 1: Intervention group: Pre- and postoperative treatment by oral probiotic drug after colorectal surgery. Intervention 2: Control group: Routine pre- and postoperative treatment of colorectal surgery.
Primary outcome(s): Anastomosis rupture. Timepoint: Daily till 30 days after the operation. Method of measurement: Physical examination.;Surgical site infection. Timepoint: Daily till 30 days after the operation. Method of measurement: Physical examination.;Fascia dehiscence. Timepoint: Daily till 30 days after the operation. Method of measurement: Physical examination.;Pulmonary infection. Timepoint: Daily till 30 days after the operation. Method of measurement: Chest x-ray if clinically indicated.;Urinary infection. Timepoint: Daily till 30 days after the operation. Method of measurement: Urinalysis if clinically indicated.;Total duration of hospital stay. Timepoint: Daily. Method of measurement: Total duration of hospital stay till discharge.;Mortality. Timepoint: Daily. Method of measurement: Report of death by attending physician.
Study Design: Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The patients will be randomized between two study (who will receive the probiotic) and control (who will not receive the probiotic) groups by the random numbers produced by the website: www.randomizer.org.
| 2482659 | ecrin-mdr-crc
Project description:Intervention 1: Intervention group receives mindfulness-based stress reduction(MBSR). This is an eight-week group training program, Whit a meeting held every week for two hours, in which patients experientially practice body scan, sitting media, mindful walking, hatta yoga, mindful eating. Intervention 2: Control group doesn’t receive any intervention. The group to the questionnaires in Pre test and post test.
Primary outcome(s): Cancer related fatigue. Timepoint: Pre test and post test. Method of measurement: Fatigue questionnaire.;Cancer related cognitive impairment. Timepoint: Pre and post test. Method of measurement: Wechsler memory scale-Revised.;Fear of cancer recurrence. Timepoint: Pre and post test. Method of measurement: Fear of cancer recurrence inventory.;Self management strategies. Timepoint: Pre and post test. Method of measurement: Smart.
Study Design: Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Other, Purpose: Supportive, Randomization description: One methods of randomization in studies is random blocking, in this way, the number of people assigned to each group is usually approximately the same. In this method, blocks are formed based on the desired variables, and within each block, half of the intervention and half as the control are considered.The main object of this method is to balance the number of participants in each group.
| 2496134 | ecrin-mdr-crc
Project description:Gene expression data from Vietnamese subjects admitted to hospital with acute uncomplicated (n=6) or complicated (n=6) Plasmodium falciparum malaria infection had whole-blood samples collected at admission, 1 week later and 1 month later. Groups of assays that are related as part of a time series. Disease State: patient with complicated or uncomplicated Plasmodium falciparum malaria infection or Healthy control time_series_design
2016-02-15 | E-GEOD-35859 | biostudies-arrayexpress
Project description:Intervention 1: Intervention group: Patients with colorectal cancer, stage 4 which receive chemotherapy and vaccine. The allogene vaccine (including three colon cancer cell lines) will be injected in two periods. The first period consists of three consecutive doses: the first dose will be injected one week after diagnosis /surgery, the following two doses will be injected with a week interval. One week after the third injection, chemotherapy will begin. After the first period, chemotherapy begins and continues for six months. The second period of the vaccine starts one month after chemotherapy and includes three consecutive vaccine doses with a distance of one week. Chemotherapy begins and continues two weeks after the sixth injection. 300 million tumor cells (108 cells from each cancer cell line) with 1 million BCG organisms are injected intradermally in the first and second injections. The third, fourth, fifth, and sixth injections contain 300 million irradiated tumor cells. Intervention 2: Control group: Patients with colorectal cancer, stage 4 which receive Chemotherapy treatment 5 weeks after diagnosis /surgery.
Primary outcome(s): Measuring the levels of CA19-9. Timepoint: 6 months after the last vaccination. Method of measurement: via Elisa method.;Measuring the levels of CEA. Timepoint: 6 months after the last vaccination. Method of measurement: via Elisa method.;Measuring the levels of alanine aminotransferase. Timepoint: 6 months after the last vaccination. Method of measurement: via Elisa method.;Measuring the levels of aspartate aminotransferase. Timepoint: 6 months after the last vaccination. Method of measurement: via Elisa method.;Measuring the levels of alkaline phosphatase. Timepoint: 6 months after the last vaccination. Method of measurement: via Elisa method.;Measuring the levels of glutamyl tarnspeptidase. Timepoint: 6 months after the last vaccination. Method of measurement: via Elisa method.;Investigation of tumor formation. Timepoint: 6 months after the last vaccination. Method of measurement: via colonoscopy.
Study Design: Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.
| 2504200 | ecrin-mdr-crc
Project description:Gene expression data from whole-blood collected from Kenyan children with Plasmodium falciparum malaria infection at acute hospital admission (n=15) and at convalescence (n=9). A clinical history design type is where the organisms clinical history of diagnosis, treatments, e.g. vaccinations, surgery etc. Disease State: with Plasmodium falciparum malaria infection at acute hospital admission and at convalescence clinical_history_design
2016-02-15 | E-GEOD-35860 | biostudies-arrayexpress